Barry, OppHub America Desk · · Source: yahoo-tickers-tape-movers
$BEN Fund Outperforms Biotech Index With 13% Annualized Return
Investors seeking exposure to biotech's potential for outsized returns may consider funds demonstrating consistent alpha generation, such as the Franklin Biotechnology Discovery Fund, which has outpaced its benchmark.
Based on reporting from yahoo-tickers-tape-movers.
Franklin Biotechnology Discovery Fund has delivered a notable 13% five-year annualized return, significantly outpacing the biotech index ETF's 5.3%. This performance highlights the fund's active management effectiveness in a sector often driven by specific innovation.
Market context for this story
As of: After HoursLoading quotes…
Informational only — not investment advice. Full markets →
Franklin Resources·$BEN$BENFranklin Resources
TradingView
Live chart & market data via TradingView · OppHub classroom · Delayed or exchange real-time per TradingView data agreements · Not investment advice
Educational TradingView chart — search any symbol in the widget. Confirm on /markets/BEN. Not investment advice.
Related markets
Shares a vertical MP4 loop to your phone's camera roll or app share sheet (Instagram, TikTok, Facebook Reels).
Franklin Biotechnology Discovery Fund has achieved a 13% five-year annualized return, substantially exceeding the 5.3% return of a comparable biotech index ETF. This disparity suggests potential alpha generation within the fund through strategic selection of biotech assets.
### Catalyst Analysis: Fund Performance
### Technical Analysis & Key Risk Watch
Key levels for $BEN+WL (educational): R2 $34.18 · R1 $33.94 · last $33.86 · S1 $33.62 · S2 $33.27.
$BEN+WL last traded at $33.86, up 2.08% for the day, with an RSI14 of 58.1. Key levels to watch include resistance at $34.18 and support at $33.27. Volume traded at 2.71x its 20-day average.
### Impact on Biotech Sector Funds
Read the full story
Original reporting and related coverage — attribution links only, not paid recommendations.
Trade this story
Robinhood
Webull
Tradier
IBKR
Chart this story
TradingView
Broker and exchange buttons use invite / refer-a-friend links (rewards may be capped). Charting links (TradingView) are partner offers that may pay OppHub America a commission at no extra cost to you.
OppSHOP
Full OppSHOP →As an Amazon Associate, OppHub America earns from qualifying purchases. Shopping here helps keep the site free — at no extra cost to you. Disclosure
OppSHOP
Related to this story
Investors seeking exposure to biotech's potential for outsized returns m
Shop related →
Investing books
Read the classics
Shop this pick →
Personal finance books
Run the household books
Shop this pick →
Trading notebooks
Write the thesis first
Shop this pick →
Monitor for charts
See every pane
Shop this pick →
Story playbook
A pre-built map of what to watch — stocks, ETFs, and educational next steps. Not personalized advice.
Snapshot date: August 19, 2026 at 4:31 AM ET
This playbook was built when the story published and is not live-updated. Prices, news, and risk can change after this date — treat it as a starting map, not a current trade ticket.
Story → money map
biotech active management
A specific biotech mutual fund made much more money over five years than the standard stock market index for biotech. Investors care because it shows that picking specific medical companies can beat just buying the whole basket.
What changed
Franklin Biotechnology Discovery Fund significantly outperformed the passive biotech index over a five-year period.
Who wins / who loses
Active biotech fund managers and their holdings win, while passive index funds in this sector lag behind.
Time horizon
Think in terms of the next few months.
Confidence & best fit
medium confidence · Long-term investor
Safer theme exposure (ETFs)
Baskets that own the theme without betting on one company.
Single stocks (higher risk)
Primary = closest to the story · Peers = same industry · Second-order = knock-on effects · Avoid = looks related but may be a trap
Primary
- $BENWatch — track, don’t rush
The parent company of the winning fund, which could see more customer money flowing in.
View $BEN chart → · End-of-day delayed data
Peer
- $LLYBuild slowly — only if it fits your plan
A giant drug maker that often drives the big gains in healthcare funds.
View $LLY chart → · End-of-day delayed data
- $NVOBuild slowly — only if it fits your plan
A leading medical company helping health funds look good.
View $NVO chart → · End-of-day delayed data
Second-order
- $PFEWatch — track, don’t rush
A traditional drug giant used to measure how well smaller innovators do.
View $PFE chart → · End-of-day delayed data
Options (education only)
No strikes or expiries — a framework for how traders might express the view. Options can expire worthless.
Beginners should skip options here and just look at holding the funds or stocks directly.
See options-friendly brokers →Income / OppHub America angle
Not a trade tip — ways to use the insight outside the market.
- Research actively managed healthcare mutual funds in your retirement account.
What would break this thesis
- A sharp reversal in biotech sector sentiment or underperformance of top fund holdings like LLY and NVO.
What to do next on OppHub America
Saved playbooks stay on this device for now.
Important
Not financial advice. OppHub America playbooks are educational market maps only — not recommendations to buy, sell, or hold any security. Markets move fast; information can be wrong or outdated. Trade and invest at your own risk. Do your own research or consult a licensed advisor.
Based on reporting from yahoo-tickers-tape-movers.
Informational and educational only — not investment, financial, or legal advice. Disclosure
Shares a vertical MP4 loop to your phone's camera roll or app share sheet (Instagram, TikTok, Facebook Reels).